Spermidine Encyclopedia — Scientific Background

What Is Spermidine?

Spermidine (CAS 124-20-9 for free base; CAS 334-50-9 for trihydrochloride) is a naturally occurring polyamine with the chemical name N-(3-aminopropyl)butane-1,4-diamine. It is synthesized from the diamine putrescine and is present in all living organisms. The molecular weight of the free base is 145.25 g/mol, while the trihydrochloride salt has a molecular formula of C₇H₂₂Cl₃N₃ and a molecular weight of 254.63 g/mol. Spermidine is a ubiquitous, endogenous polyamine involved in sustaining cellular and neuronal homeostasis.

Dietary Sources

Spermidine is present in a wide variety of foods, with the highest concentrations found in:

• Wheat Germ — Among grains, wheat germ has the highest amount of polyamines, especially spermidine

• Soybean Products — Rich dietary source

• Fermented Foods — Cheese, miso, and other fermented products

• Vegetables — Mushrooms, spinach, cauliflower, broccoli, peas

• Fruits — Apple, banana, avocado, kiwi, orange, strawberry

• Nuts — Hazelnut, almond, pistachio, chestnut

• Animal Products — Veal, beef, chicken, pork, turkey, duck meat, milk, and egg

Mechanisms of Action

Autophagy Induction — The Core Mechanism

The most well-documented mechanism of spermidine is the induction of autophagy, a cellular recycling process that removes damaged organelles and protein aggregates. This process is crucial for maintaining cellular homeostasis and is implicated in spermidine’s anti-aging effects. Spermidine triggers autophagy through multiple pathways, including inhibition of mTOR signaling and activation of AMPK. Single-cell RNA-seq after spermidine treatment revealed increased expression of TFEB targets and autophagy-related genes, in line with elevated autophagic flux.

Immunosenescence Modulation

Spermidine has been shown to counteract immunosenescence and induce autophagy in preclinical models, and its levels decline with age in humans. In a clinical trial, vaccine non-responders exhibited a distinct immune-senescence signature marked by elevated p16, mTOR signalling, and γ-H2AX+ DNA damage in lymphocytes. Spermidine reversed these features and significantly enhanced spike-specific IgG secretion, memory B cell recall responses, and neutralising antibody activity specifically in non-responders.

Anti-Inflammatory Activity

Spermidine can reduce the expression of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6. It can also inhibit the translocation of NF-κB and the accumulation of reactive oxygen species (ROS), contributing to its anti-inflammatory and cytoprotective effects.

Lipid Metabolism Regulation

Spermidine can regulate lipid metabolism by suppressing the expression of genes involved in lipid synthesis through the AMP-activated protein kinase (AMPK) signaling pathway.

Signaling Pathway Interactions

Spermidine interacts with various signaling pathways involved in aging and cellular metabolism, such as the SIRT1/PGC-1α and AMPK pathways, contributing to its broad geroprotective effects.

The Bioavailability Challenge

Despite its essential physiological functions, native spermidine presents significant formulation challenges. The compound is highly hygroscopic and sensitive to oxidation, which limits its stability in powder and aqueous formulations. Spermidine also undergoes rapid metabolism and excretion, limiting its systemic bioavailability following oral administration. These limitations have driven the development of liposomal encapsulation as an advanced delivery strategy to enhance spermidine stability, dispersion, and bioavailability.

Liposomal Spermidine

Liposomal encapsulation of spermidine provides a fundamentally different delivery mechanism from conventional forms. The plant-derived phospholipid bilayer surrounds the spermidine molecule, forming a protective shell that enhances stability, dispersion, and cellular uptake. This delivery system:

• Protects spermidine from moisture absorption and oxidative degradation

• Achieves ≥80% encapsulation efficiency (typically ~83%)

• Provides rehydrated particle size of 80–300 nm with PDI ≤0.35

• Enables water dispersibility for use in aqueous formulations

• Delivers spermidine encapsulated in phospholipid liposomes for improved bioavailability and slower, steadier release

Liposomal spermidine powder pairs nature-identical spermidine with plant-derived phospholipids, presented as a clean powder at 50% or 70% active strength. The advanced liposomal encapsulation coats the polyamine within a protective phospholipid bilayer shield—a cellular-matching structure that prevents moisture absorption, locks in ambient stability, and significantly optimizes ingredient dispersion and bioavailability in advanced supplement formulations.

Clinical Evidence

Immune Function — Randomized Controlled Trial

A double-blind, randomized, placebo-controlled pilot study was conducted in 40 adults over 65 years of age following their third SARS-CoV-2 vaccine dose to assess the safety of spermidine and its effects on vaccine-induced immunity. Daily oral supplementation (6 mg, 13 weeks) was well-tolerated. Vaccine non-responsiveness was common, and non-responders exhibited a distinct immune-senescence signature marked by elevated p16, mTOR signalling, and γ-H2AX+ DNA damage in lymphocytes. Spermidine reversed these features and significantly enhanced spike-specific IgG secretion, memory B cell recall responses, and neutralising antibody activity, specifically in non-responders. Single-cell RNA-seq after treatment revealed increased expression of TFEB targets and autophagy-related genes in B cells, in line with elevated autophagic flux. These findings suggest that targeting immune cell senescence with spermidine may improve vaccine responsiveness in older adults.

Dose-Escalation Study

An open-label study is enrolling approximately 10 healthy adult volunteers aged 18–75 years, focusing on safety and biological responses to gradually increasing spermidine doses over 112 days. Participants receive spermidine in capsule form through three consecutive 28-day courses, with doses escalating from 40 mg to 120 mg and finally to 400 mg. The study will monitor changes in immune biomarkers, cytokine levels, and various immune cell subsets, while also performing detailed metabolomics profiles.

German Clinical Trial

A German Clinical Trials Register study evaluated varying daily doses of 12 mg, 24 mg, 48 mg, and 96 mg orally per day across four groups, assessing safety and biological effects.

Broad Healthspan Evidence

Human interventional evaluations have reviewed trial regimens ranging from 1.5 mg to 3.3 mg daily of spermidine derived from rice germ extract to high-purity spermidine trihydrochloride at 40 mg daily across healthy elderly cohorts.

Safety and Regulatory

Spermidine is naturally present in the human body and is generally well tolerated. In a randomized controlled trial, daily oral supplementation (6 mg, 13 weeks) was well-tolerated in adults over 65 years. Spermidine is a naturally occurring non-toxic autophagy inducer. Regulatory status varies by region. In the European Union, spermidine is classified as a novel food ingredient in certain applications. In the United States, spermidine is available as a dietary supplement. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

599$/KG

469$/KG